View Post 2 min This content is machine translated Pancreatic Cancer Resection outcome and pCR rate improved Chemotherapy (CT) is the standard treatment for non-resectable, locally advanced pancreatic cancer. The CONKO-007 study investigated the role of sequential CT and chemoradiotherapy (CRT). The first results have now been…
View Post 4 min This content is machine translated Gastrointestinal tumors Stomach and pancreatic cancer – two entities, one poor prognosis Unprecedented advances have been made in the treatment of gastrointestinal cancer over the past 25 years. At this year’s World Congress, nearly 3000 clinicians, researchers and practitioners discussed the latest…
View Post 3 min This content is machine translated Advanced pancreatic cancer First-line therapies in the Real Life Check Currently, gemcitabine plus Nab-paclitaxel and FOLFIRINOX are considered standard first-line therapies for advanced pancreatic cancer. So far, there is no direct comparison of these options. An analysis of the German…
View Post 10 min This content is machine translated Visceral Surgery Update - Part 1 Upper gastrointestinal tract and COVID-19 complications. Approximately 60 per 1000 population undergo abdominal surgery annually. The majority of patients are initially evaluated and triaged in the primary care physician’s office. Visceral surgery is also constantly evolving,…
View Post 3 min This content is machine translated Gastrointestinal tumors Latest scientific findings and real-life data The best-scored abstracts in gastrointestinal tumors show a range of promising new findings. Thus, initial data on first-line therapy of advanced hepatocellular carcinoma could be presented as well as real-life…
View Post 2 min This content is machine translated Pancreatic Cancer Effectiveness of treatment depends on molecular prerequisites Pancreatic cancer is one of the greatest challenges in oncologic therapy. Mortality is extremely high despite intensive research. New treatment options are urgently needed. A team of researchers has now…
View Post 11 min This content is machine translated Developments in pancreatic cancer Pancreatic cancer – still particularly aggressive and deadly Pancreatic cancer is the seventh most common cancer diagnosis in Switzerland. However, it ranks fourth in terms of mortality, which illustrates the aggressiveness of the tumor. Various studies, especially in…
View Post 3 min This content is machine translated World Pancreatic Cancer Day November 16, 2017 The world sees purple Pancreatic cancer has a very high mortality. In Switzerland, 1172 people fall ill with it every year, 1080 die. At Shire’s media briefing, a comprehensive overview of the disease was…
View Post 3 min This content is machine translated Venous thromboembolism Do patients with pancreatic cancer benefit from prophylaxis? Advanced pancreatic cancer is associated with a significantly increased risk of venous thromboembolism: within one year, approximately one fifth of patients suffer such a complication – with devastating consequences. What…
